[Need for gastric acidification in the treatment of abdominal migraine. Results of a multicenter study on the association of Séglor retard and Vagosérine].
D000328:Adult; D000368:Aged; D004087:Dihydroergotamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D005971:Glutamates / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000150:complications / Q000188:drug therapy*; D010206:Papain / Q000627:therapeutic use*; D010830:Physostigmine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D004338:Drug Combinations; D005971:Glutamates; D004087:Dihydroergotamine; C024165:vagoserine; D010830:Physostigmine; D010206:Papain
Nécessité de l'acidification gastrique dans le traitement des migraines digestives. Résultats d'une étude multicentrique sur l'association Séglor retard--Vagosérine.